Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer.

@article{Furukawa2016OncologicOO,
  title={Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer.},
  author={Junya Furukawa and Hideaki Miyake and Taka-aki Inoue and Takayoshi Ogawa and Hirokazu Tanaka and Masato Ishigami Fujisawa},
  journal={Current urology},
  year={2016},
  volume={9 2},
  pages={67-72}
}
BACKGROUND The objective of this study was to review our experience with radical prostatectomy (RP) as monotherapy for men with high-risk prostate cancer (PCa). PATIENTS AND METHODS This study included 382 consecutive patients who were diagnosed with high-risk PCa according to the D'Amico definition and subsequently underwent RP without neoadjuvant therapy. Biochemical recurrence (BR) was defined as a serum prostate-specific antigen (PSA) level ≥ 0.2 ng/ml on two consecutive measurements, and… CONTINUE READING